 Susan Calcaterra
Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Opioid-Related Disorders | 27 | 2026 | 600 | 8.820 |
Why?
| | Buprenorphine | 14 | 2024 | 190 | 5.640 |
Why?
| | Methadone | 14 | 2026 | 121 | 5.210 |
Why?
| | Analgesics, Opioid | 35 | 2025 | 1143 | 4.700 |
Why?
| | Opiate Substitution Treatment | 14 | 2026 | 187 | 4.480 |
Why?
| | Hospitalization | 18 | 2026 | 2433 | 3.490 |
Why?
| | Naltrexone | 3 | 2026 | 117 | 2.430 |
Why?
| | Narcotic Antagonists | 9 | 2026 | 205 | 2.280 |
Why?
| | Addiction Medicine | 3 | 2024 | 14 | 2.230 |
Why?
| | Hospitalists | 5 | 2021 | 266 | 2.190 |
Why?
| | Substance-Related Disorders | 10 | 2026 | 1094 | 1.990 |
Why?
| | Substance Withdrawal Syndrome | 6 | 2023 | 186 | 1.670 |
Why?
| | Patient Discharge | 7 | 2025 | 983 | 1.610 |
Why?
| | Alcoholism | 4 | 2024 | 817 | 1.430 |
Why?
| | Acute Pain | 4 | 2024 | 55 | 1.160 |
Why?
| | Pain Management | 5 | 2024 | 405 | 1.160 |
Why?
| | Medical Marijuana | 2 | 2020 | 123 | 1.080 |
Why?
| | Qualitative Research | 8 | 2025 | 1671 | 1.050 |
Why?
| | Central Nervous System Stimulants | 3 | 2015 | 185 | 1.030 |
Why?
| | Attitude of Health Personnel | 4 | 2024 | 1185 | 1.010 |
Why?
| | Hepatitis C | 3 | 2025 | 254 | 0.960 |
Why?
| | Pharmacists | 3 | 2026 | 240 | 0.950 |
Why?
| | Drug Overdose | 6 | 2019 | 370 | 0.910 |
Why?
| | Harm Reduction | 1 | 2026 | 51 | 0.900 |
Why?
| | Pharmacy Service, Hospital | 1 | 2026 | 81 | 0.880 |
Why?
| | Alcohol Deterrents | 1 | 2024 | 26 | 0.860 |
Why?
| | Humans | 65 | 2026 | 144759 | 0.850 |
Why?
| | Hospitals | 7 | 2025 | 730 | 0.820 |
Why?
| | Amphetamine-Related Disorders | 1 | 2024 | 48 | 0.810 |
Why?
| | Hospital Medicine | 3 | 2022 | 92 | 0.810 |
Why?
| | Practice Patterns, Physicians' | 10 | 2025 | 1356 | 0.810 |
Why?
| | Liver Diseases, Alcoholic | 1 | 2024 | 97 | 0.810 |
Why?
| | Chronic Pain | 6 | 2022 | 290 | 0.800 |
Why?
| | Methamphetamine | 1 | 2024 | 70 | 0.800 |
Why?
| | Referral and Consultation | 4 | 2022 | 851 | 0.790 |
Why?
| | Adult | 31 | 2026 | 40449 | 0.730 |
Why?
| | Decision Support Systems, Clinical | 2 | 2025 | 265 | 0.710 |
Why?
| | Cause of Death | 3 | 2013 | 471 | 0.710 |
Why?
| | Liver Diseases | 1 | 2024 | 304 | 0.690 |
Why?
| | Naloxone | 6 | 2025 | 132 | 0.680 |
Why?
| | Benzodiazepines | 2 | 2022 | 167 | 0.660 |
Why?
| | Prisoners | 2 | 2014 | 143 | 0.660 |
Why?
| | Prescription Drug Misuse | 2 | 2018 | 51 | 0.630 |
Why?
| | Medicine | 1 | 2021 | 125 | 0.590 |
Why?
| | Middle Aged | 23 | 2026 | 35875 | 0.590 |
Why?
| | Antiviral Agents | 1 | 2025 | 767 | 0.590 |
Why?
| | Drug Substitution | 1 | 2019 | 63 | 0.580 |
Why?
| | United States | 14 | 2025 | 15966 | 0.580 |
Why?
| | Internationality | 1 | 2019 | 156 | 0.550 |
Why?
| | Physicians | 2 | 2024 | 939 | 0.520 |
Why?
| | Poison Control Centers | 1 | 2018 | 84 | 0.520 |
Why?
| | Male | 30 | 2026 | 72315 | 0.510 |
Why?
| | Female | 30 | 2026 | 78271 | 0.510 |
Why?
| | Healthcare Disparities | 1 | 2024 | 727 | 0.500 |
Why?
| | Health Services Accessibility | 2 | 2024 | 1098 | 0.480 |
Why?
| | Inpatients | 4 | 2026 | 545 | 0.480 |
Why?
| | Burnout, Professional | 1 | 2022 | 484 | 0.460 |
Why?
| | Marijuana Smoking | 1 | 2019 | 250 | 0.460 |
Why?
| | Global Health | 1 | 2019 | 401 | 0.460 |
Why?
| | Electronic Health Records | 4 | 2025 | 1173 | 0.450 |
Why?
| | Injections, Intramuscular | 2 | 2026 | 141 | 0.440 |
Why?
| | Cancer Survivors | 1 | 2020 | 327 | 0.440 |
Why?
| | Drug Users | 1 | 2015 | 42 | 0.430 |
Why?
| | Retrospective Studies | 15 | 2022 | 17066 | 0.420 |
Why?
| | Perception | 1 | 2017 | 377 | 0.400 |
Why?
| | Emergency Service, Hospital | 4 | 2023 | 2310 | 0.400 |
Why?
| | Cannabis | 1 | 2020 | 509 | 0.370 |
Why?
| | Patient Satisfaction | 1 | 2017 | 704 | 0.370 |
Why?
| | Colorectal Neoplasms | 1 | 2020 | 845 | 0.360 |
Why?
| | Alcohol Drinking | 1 | 2019 | 826 | 0.360 |
Why?
| | Prescription Drugs | 1 | 2013 | 111 | 0.340 |
Why?
| | Databases, Factual | 3 | 2017 | 1486 | 0.330 |
Why?
| | Pain | 1 | 2016 | 779 | 0.320 |
Why?
| | Interviews as Topic | 3 | 2024 | 901 | 0.320 |
Why?
| | Cocaine | 1 | 2012 | 160 | 0.320 |
Why?
| | Surveys and Questionnaires | 7 | 2025 | 6048 | 0.320 |
Why?
| | Mental Health Services | 1 | 2015 | 473 | 0.300 |
Why?
| | Young Adult | 9 | 2024 | 14105 | 0.290 |
Why?
| | Patient Acceptance of Health Care | 1 | 2015 | 885 | 0.270 |
Why?
| | Internal Medicine | 2 | 2024 | 280 | 0.270 |
Why?
| | Inappropriate Prescribing | 2 | 2017 | 63 | 0.240 |
Why?
| | Adolescent | 9 | 2024 | 22428 | 0.240 |
Why?
| | Forecasting | 2 | 2018 | 391 | 0.240 |
Why?
| | Cohort Studies | 4 | 2025 | 5960 | 0.230 |
Why?
| | Stress, Psychological | 1 | 2014 | 1152 | 0.230 |
Why?
| | Colorado | 5 | 2019 | 4564 | 0.220 |
Why?
| | Professional Role | 1 | 2026 | 158 | 0.210 |
Why?
| | Hospitals, Psychiatric | 1 | 2024 | 27 | 0.210 |
Why?
| | Analgesics | 2 | 2017 | 228 | 0.210 |
Why?
| | Program Evaluation | 2 | 2026 | 948 | 0.190 |
Why?
| | Narcotics | 1 | 2023 | 55 | 0.190 |
Why?
| | Administration, Oral | 1 | 2024 | 847 | 0.180 |
Why?
| | Internship and Residency | 2 | 2024 | 1257 | 0.180 |
Why?
| | Aftercare | 1 | 2023 | 223 | 0.170 |
Why?
| | Morpholines | 1 | 2022 | 128 | 0.170 |
Why?
| | Patients | 1 | 2023 | 180 | 0.170 |
Why?
| | Social Workers | 1 | 2021 | 56 | 0.170 |
Why?
| | Time Factors | 3 | 2025 | 7173 | 0.170 |
Why?
| | Cost-Benefit Analysis | 2 | 2023 | 634 | 0.160 |
Why?
| | Communication Barriers | 1 | 2022 | 124 | 0.160 |
Why?
| | Drug Administration Schedule | 3 | 2018 | 779 | 0.160 |
Why?
| | Prescriptions | 1 | 2020 | 76 | 0.160 |
Why?
| | Aged | 7 | 2024 | 25913 | 0.150 |
Why?
| | Nausea | 1 | 2020 | 111 | 0.150 |
Why?
| | Drug Prescriptions | 2 | 2025 | 284 | 0.150 |
Why?
| | Social Stigma | 1 | 2021 | 171 | 0.150 |
Why?
| | Interrupted Time Series Analysis | 1 | 2019 | 75 | 0.140 |
Why?
| | Time | 1 | 2018 | 86 | 0.140 |
Why?
| | Attitude | 1 | 2020 | 260 | 0.140 |
Why?
| | Safety-net Providers | 1 | 2019 | 125 | 0.130 |
Why?
| | Patient Preference | 2 | 2018 | 224 | 0.130 |
Why?
| | Terminology as Topic | 1 | 2019 | 255 | 0.120 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2017 | 51 | 0.120 |
Why?
| | Regression Analysis | 1 | 2019 | 1003 | 0.120 |
Why?
| | Counseling | 1 | 2020 | 408 | 0.120 |
Why?
| | South Carolina | 1 | 2016 | 48 | 0.120 |
Why?
| | Drug Utilization | 1 | 2017 | 166 | 0.120 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2019 | 2027 | 0.120 |
Why?
| | Consensus | 1 | 2018 | 488 | 0.120 |
Why?
| | Quality of Life | 2 | 2020 | 3185 | 0.120 |
Why?
| | Ambulatory Care | 1 | 2020 | 600 | 0.110 |
Why?
| | Survival Rate | 1 | 2020 | 2089 | 0.110 |
Why?
| | Mental Disorders | 1 | 2024 | 1168 | 0.110 |
Why?
| | Community Health Planning | 1 | 2015 | 41 | 0.110 |
Why?
| | General Practice | 1 | 2015 | 32 | 0.110 |
Why?
| | Prospective Studies | 2 | 2020 | 7990 | 0.110 |
Why?
| | Primary Health Care | 3 | 2023 | 1733 | 0.110 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5868 | 0.100 |
Why?
| | Prognosis | 2 | 2020 | 4282 | 0.100 |
Why?
| | Unemployment | 1 | 2014 | 42 | 0.100 |
Why?
| | Quality Indicators, Health Care | 1 | 2017 | 335 | 0.100 |
Why?
| | Societies, Medical | 1 | 2018 | 887 | 0.100 |
Why?
| | Guideline Adherence | 1 | 2018 | 589 | 0.100 |
Why?
| | Topography, Medical | 1 | 2013 | 11 | 0.100 |
Why?
| | Community Health Services | 1 | 2015 | 233 | 0.100 |
Why?
| | Housing | 1 | 2014 | 144 | 0.100 |
Why?
| | Respiratory Insufficiency | 1 | 2016 | 326 | 0.090 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2024 | 1414 | 0.090 |
Why?
| | Washington | 1 | 2012 | 147 | 0.090 |
Why?
| | Drug Interactions | 1 | 2012 | 398 | 0.080 |
Why?
| | Interpersonal Relations | 1 | 2014 | 400 | 0.080 |
Why?
| | Follow-Up Studies | 1 | 2020 | 5408 | 0.080 |
Why?
| | Risk Factors | 3 | 2018 | 10779 | 0.080 |
Why?
| | Survival Analysis | 1 | 2012 | 1382 | 0.070 |
Why?
| | Proportional Hazards Models | 1 | 2012 | 1325 | 0.070 |
Why?
| | Aged, 80 and over | 2 | 2018 | 8265 | 0.070 |
Why?
| | Infant, Newborn | 1 | 2020 | 6429 | 0.070 |
Why?
| | Interferon-alpha | 1 | 2008 | 197 | 0.060 |
Why?
| | Sex Characteristics | 1 | 2013 | 790 | 0.060 |
Why?
| | Case-Control Studies | 1 | 2015 | 3604 | 0.060 |
Why?
| | Pregnancy | 1 | 2020 | 7190 | 0.060 |
Why?
| | Anti-Bacterial Agents | 1 | 2017 | 1907 | 0.060 |
Why?
| | Leukocytes, Mononuclear | 1 | 2008 | 573 | 0.060 |
Why?
| | Delphi Technique | 1 | 2025 | 329 | 0.050 |
Why?
| | Phenobarbital | 1 | 2023 | 19 | 0.050 |
Why?
| | Weight-Bearing | 1 | 2003 | 181 | 0.050 |
Why?
| | Life Expectancy | 1 | 2023 | 72 | 0.050 |
Why?
| | Arthritis, Experimental | 1 | 2003 | 141 | 0.040 |
Why?
| | Osteoarthritis | 1 | 2003 | 196 | 0.040 |
Why?
| | Logistic Models | 2 | 2016 | 2117 | 0.040 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 338 | 0.040 |
Why?
| | International Classification of Diseases | 1 | 2019 | 147 | 0.030 |
Why?
| | Medical Audit | 1 | 2017 | 77 | 0.030 |
Why?
| | Health Transition | 1 | 2016 | 8 | 0.030 |
Why?
| | Prescription Drug Overuse | 1 | 2016 | 10 | 0.030 |
Why?
| | Medical Records | 1 | 2017 | 187 | 0.030 |
Why?
| | Clinical Competence | 1 | 2024 | 1244 | 0.030 |
Why?
| | Reproducibility of Results | 2 | 2019 | 3409 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2016 | 539 | 0.030 |
Why?
| | United States Department of Veterans Affairs | 1 | 2018 | 768 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2017 | 547 | 0.030 |
Why?
| | Health Surveys | 1 | 2015 | 518 | 0.020 |
Why?
| | Models, Statistical | 1 | 2018 | 681 | 0.020 |
Why?
| | Odds Ratio | 1 | 2015 | 1075 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1539 | 0.020 |
Why?
| | Communication | 1 | 2018 | 965 | 0.020 |
Why?
| | Patient Education as Topic | 1 | 2015 | 780 | 0.020 |
Why?
| | Risk Assessment | 1 | 2018 | 3671 | 0.020 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2008 | 186 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2008 | 758 | 0.010 |
Why?
| | RNA-Binding Proteins | 1 | 2008 | 462 | 0.010 |
Why?
| | Iodoacetates | 1 | 2003 | 3 | 0.010 |
Why?
| | Hindlimb | 1 | 2003 | 131 | 0.010 |
Why?
| | Rats, Wistar | 1 | 2003 | 451 | 0.010 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2003 | 123 | 0.010 |
Why?
| | Proteins | 1 | 2008 | 1021 | 0.010 |
Why?
| | Acetaminophen | 1 | 2003 | 264 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2008 | 2608 | 0.010 |
Why?
| | Disease Progression | 1 | 2003 | 2847 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2003 | 2925 | 0.010 |
Why?
| | Rats | 1 | 2003 | 5597 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2003 | 11679 | 0.000 |
Why?
| | Animals | 1 | 2003 | 38058 | 0.000 |
Why?
|
|
Calcaterra's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|